BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 18845441)

  • 21. Synthesis, antitumor evaluation and microarray study of some new pyrazolo[3,4-d][1,2,3]triazine derivatives.
    Nasr T; Bondock S; Youns M; Fayad W; Zaghary W
    Eur J Med Chem; 2017 Dec; 141():603-614. PubMed ID: 29107422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antitumor characterization of pyrazolic analogues of the marine pyrroloquinoline alkaloids: wakayin and tsitsikammamines.
    Legentil L; Benel L; Bertrand V; Lesur B; Delfourne E
    J Med Chem; 2006 May; 49(10):2979-88. PubMed ID: 16686539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of thiobenzanilides as anticancer agents.
    Hu WP; Yu HS; Chen YR; Tsai YM; Chen YK; Liao CC; Chang LS; Wang JJ
    Bioorg Med Chem; 2008 May; 16(9):5295-302. PubMed ID: 18359635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
    El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA
    Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-Methyl-3H-pyrazolo[1,2-a]benzo[1,2,3,4]tetrazin-3-ones. Design, synthesis, and biological activity of new antitumor agents.
    Almerico AM; Mingoia F; Diana P; Barraja P; Lauria A; Montalbano A; Cirrincione G; Dattolo G
    J Med Chem; 2005 Apr; 48(8):2859-66. PubMed ID: 15828824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cells.
    Carraro F; Pucci A; Naldini A; Schenone S; Bruno O; Ranise A; Bondavalli F; Brullo C; Fossa P; Menozzi G; Mosti L; Manetti F; Botta M
    J Med Chem; 2004 Mar; 47(7):1595-8. PubMed ID: 15027847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agents.
    Lin R; Connolly PJ; Lu Y; Chiu G; Li S; Yu Y; Huang S; Li X; Emanuel SL; Middleton SA; Gruninger RH; Adams M; Fuentes-Pesquera AR; Greenberger LM
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4297-302. PubMed ID: 17532631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part III.
    Cerecetto H; González M; Risso M; Saenz P; Olea-Azar C; Bruno AM; Azqueta A; De Ceráin AL; Monge A
    Arch Pharm (Weinheim); 2004 May; 337(5):271-80. PubMed ID: 15095420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and in vitro cytotoxic activity of novel pyrazolo[3,4-d]pyrimidines and related pyrazole hydrazones toward breast adenocarcinoma MCF-7 cell line.
    Hassan GS; Kadry HH; Abou-Seri SM; Ali MM; Mahmoud AE
    Bioorg Med Chem; 2011 Nov; 19(22):6808-17. PubMed ID: 22000322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity.
    Bindi S; Fancelli D; Alli C; Berta D; Bertrand JA; Cameron AD; Cappella P; Carpinelli P; Cervi G; Croci V; D'Anello M; Forte B; Giorgini ML; Marsiglio A; Moll J; Pesenti E; Pittalà V; Pulici M; Riccardi-Sirtori F; Roletto F; Soncini C; Storici P; Varasi M; Volpi D; Zugnoni P; Vianello P
    Bioorg Med Chem; 2010 Oct; 18(19):7113-20. PubMed ID: 20817473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of new podophyllic aldehyde derivatives with cytotoxic and apoptosis-inducing activities.
    Castro MA; del Corral JM; García PA; Rojo MV; de la Iglesia-Vicente J; Mollinedo F; Cuevas C; San Feliciano A
    J Med Chem; 2010 Feb; 53(3):983-93. PubMed ID: 20067289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isoindolo[2,1-c]benzo[1,2,4]triazines: a new ring system with antiproliferative activity.
    Diana P; Martorana A; Barraja P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G
    Bioorg Med Chem; 2007 Jan; 15(1):343-9. PubMed ID: 17064918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radical properties governing the hypoxia-selective cytotoxicity of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxides.
    Anderson RF; Shinde SS; Hay MP; Gamage SA; Denny WA
    Org Biomol Chem; 2005 Jun; 3(11):2167-74. PubMed ID: 15917906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of antitumor activity of pyrazole oxime ethers.
    Park HJ; Lee K; Park SJ; Ahn B; Lee JC; Cho H; Lee KI
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3307-12. PubMed ID: 15922597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-selective 3-alkyl 1,2,4-benzotriazine 1,4-dioxides: the influence of hydrogen bond donors on extravascular transport and antitumor activity.
    Hay MP; Pchalek K; Pruijn FB; Hicks KO; Siim BG; Anderson RF; Shinde SS; Phillips V; Denny WA; Wilson WR
    J Med Chem; 2007 Dec; 50(26):6654-64. PubMed ID: 18052317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solid-phase synthesis and antitumor evaluation of 2,4-diamino-6-aryl-1,3,5-triazines.
    Hu Z; Ma T; Chen Z; Ye Z; Zhang G; Lou Y; Yu Y
    J Comb Chem; 2009 Mar; 11(2):267-73. PubMed ID: 19125569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, characterization, antiamoebic activity and cytotoxicity of new pyrazolo[3, 4-d]pyrimidine-6-one derivatives.
    Hayat F; Salahuddin A; Azam A
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):472-9. PubMed ID: 21054147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The activity of pyrazolo[4,3-
    Szymanowska A; Radomska D; Czarnomysy R; Mojzych M; Kotwica-Mojzych K; Bielawski K; Bielawska A
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2343352. PubMed ID: 38700244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of intrinsic apoptosis pathway in colon cancer HCT-116 cells by novel 2-substituted-5,6,7,8-tetrahydronaphthalene derivatives.
    Gamal-Eldeen AM; Hamdy NA; Abdel-Aziz HA; El-Hussieny EA; Fakhr IM
    Eur J Med Chem; 2014 Apr; 77():323-33. PubMed ID: 24657569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyrazolo[3,4-c]pyridazines as novel and selective inhibitors of cyclin-dependent kinases.
    Braña MF; Cacho M; García ML; Mayoral EP; López B; de Pascual-Teresa B; Ramos A; Acero N; Llinares F; Muñoz-Mingarro D; Lozach O; Meijer L
    J Med Chem; 2005 Nov; 48(22):6843-54. PubMed ID: 16250643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.